The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $70.31

Today's change-1.07 -1.50%
Updated January 30 4:07 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $70.31

Today's change-1.07 -1.50%
Updated January 30 4:07 PM EST. Delayed by at least 15 minutes.

Baxter International Inc down (U.S.)$1.07

Baxter International Inc closed lower Friday, dropping (U.S.)$1.07 or 1.50% to (U.S.)$70.31. Over the last five days, shares have lost 1.57% and are down 4.07% for the last year to date. This security has underperformed the S&P 500 by 9.69% during the last year.

Key company metrics

  • Open(U.S.) $71.04
  • Previous close(U.S.) $71.38
  • High(U.S.) $71.87
  • Low(U.S.) $70.20
  • Bid / Ask-- / --
  • YTD % change-4.07%
  • Volume5,480,220
  • Average volume (10-day)3,624,264
  • Average volume (1-month)3,084,026
  • Average volume (3-month)2,836,192
  • 52-week range(U.S.) $66.34 to (U.S.) $77.31
  • Beta0.73
  • Trailing P/E19.77×
  • P/E 1 year forward15.99×
  • Forward PEG3.39×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.96%
  • Trailing EPS(U.S.) $3.56
Updated January 30 4:07 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.67%

Based on its net profit margin of 11.67%, Baxter International Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue4,4724,1974,2643,951
Total other revenue--------
Total revenue4,4724,1974,2643,951
Gross profit2,2242,0742,1161,973
Total cost of revenue2,2482,1232,1481,978
Total operating expense3,7253,6193,5483,240
Selling / general / administrative970921961903
Research & development305292292282
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)20228314777
Other operating expenses, total--------
Operating income747578716711
Interest income (expense), net non-operating---36-47-48
Gain (loss) on sale of assets--------
Other--------
Income before tax598586661709
Income after tax524447520556
Income tax, total74139141153
Net income953468520556
Total adjustments to net income--------
Net income before extra. items524447520556
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items524447520556
Inc. avail. to common incl. extra. items953468520556
Diluted net income953468520556
Dilution adjustment--------
Diluted weighted average shares547547548548
Diluted EPS excluding extraordinary itemsvalue per share0.960.820.951.01
Dividends per sharevalue per share0.520.520.520.49
Diluted normalized EPSvalue per share1.281.211.161.12